Consolidated Statements of Income (USD $) In Millions, except Per Share data, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Revenues
Premiums and fees	$ 7,793	$ 7,206	$ 23,167	$ 21,692
Net investment income	292	297	863	873
Mail order pharmacy revenues	583	471	1,625	1,333
Other revenues	66	65	201	139
Realized investment gains (losses):
Other-than-temporary impairments on fixed maturities, net	(9)	(3)	(10)	(11)
Other realized investment gains	32	30	140	203
Total realized investment gains	23	27	130	192
Total revenues	8,757	8,066	25,986	24,229
Benefits and Expenses
Global Health Care medical claims expense	4,153	3,913	12,403	11,864
Other benefit expenses	1,207	1,031	3,473	3,890
Mail order pharmacy cost of goods sold	499	390	1,382	1,096
Other operating expenses	2,080	1,933	6,156	5,739
Total benefits and expenses	7,939	7,267	23,414	22,589
Income before Income Taxes	818	799	2,572	1,640
Income taxes:
Current	289	205	928	285
Deferred	(2)	41	12	237
Total taxes	287	246	940	522
Net Income	531	553	1,632	1,118
Less: Net Income Attributable to Noncontrolling Interests	(3)	0	(3)	3
Shareholders' Net Income	$ 534	$ 553	$ 1,635	$ 1,115
Shareholder's Net Income Per Share:
Basic	$ 2.04	$ 1.99	$ 6.16	$ 3.96
Diluted	$ 2.01	$ 1.95	$ 6.05	$ 3.89
Dividends Declared Per Share	$ 0	$ 0	$ 0.04	$ 0.04